Growing community of inventors

Newtown, PA, United States of America

Robert Cohen

Average Co-Inventor Count = 5.25

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 88

Robert CohenRobert Peach (8 patents)Robert CohenJean-Claude Becker (8 patents)Robert CohenDavid Hagerty (8 patents)Robert CohenSuzette Carr (4 patents)Robert CohenSuzette Belder-Carr (4 patents)Robert CohenRobert J Peach (2 patents)Robert CohenPeter S Linsley (1 patent)Robert CohenJurgen Bajorath (1 patent)Robert CohenJoseph Naemura (1 patent)Robert CohenRobert J Peach (0 patent)Robert CohenRobert Cohen (8 patents)Robert PeachRobert Peach (43 patents)Jean-Claude BeckerJean-Claude Becker (11 patents)David HagertyDavid Hagerty (9 patents)Suzette CarrSuzette Carr (4 patents)Suzette Belder-CarrSuzette Belder-Carr (4 patents)Robert J PeachRobert J Peach (4 patents)Peter S LinsleyPeter S Linsley (77 patents)Jurgen BajorathJurgen Bajorath (23 patents)Joseph NaemuraJoseph Naemura (9 patents)Robert J PeachRobert J Peach (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bristol-myers Squibb Compnay (8 from 3,681 patents)


8 patents:

1. 10052360 - Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule

2. 9296808 - Methods for treating scleroderma by administering a soluble CTLA4 molecule

3. 8722632 - Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule

4. 8703718 - Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule

5. 8497247 - Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule

6. 8227420 - Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID

7. 8148332 - Method for treating a rheumatic disease using a soluble TLA4 molecule

8. 7455835 - Methods for treating immune system diseases using a soluble CTLA4 molecule

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…